By Martin Crutsinger

U.S. consumers slowed their spending by 0.2% in December, cutting back for a second straight month in a worrisome sign for an economy struggling under the weight of a still out-of-control pandemic.

The decline reported Friday by the Commerce Department followed a seasonally adjusted 0.7% drop in November. It was the latest sign that consumers, whose spending is the primary driver of the U.S. economy, are hunkered down and avoiding traveling, shopping, and dining out. Since making a brief bounce-back from the viral pandemic last spring, consumer spending has barely grown. Sales at retailers have declined for three straight months.

Friday's report from the government also showed that personal incomes, which provide the fuel for spending, rose a modest 0.6% after two months of declines. Yet Americans who have been fortunate enough to keep their jobs have been largely stockpiling savings rather than spending.

The latest figures reflect a shaky economy. On Thursday, the government estimated that the economy grew at a 4% annual rate in the final three months of 2020 but shrank last year by the largest amount in 74 years. At the same time, the job market is faltering, with nearly 10 million jobs still lost to the pandemic, which erupted 10 months ago. Hiring has slowed for six straight months, and employers shed jobs in December for the first time since April.

The outlook for 2021 remains uncertain. Economists warn that a sustained recovery won’t likely take hold until vaccines are successfully distributed and administered nationwide and government-enacted rescue aid spreads through the economy, which could take months. In the meantime, millions of individuals and businesses continue to struggle.

Last week, for instance, 847,000 laid-off Americans applied for unemployment benefits, an elevated figure that showed that many companies keep cutting jobs as the pandemic continues to rage. Before the virus erupted in the United States in March, weekly applications for jobless aid had never topped 700,000, even during the Great Recession.

In the coming months, as vaccines become widely distributed and administered, growth is expected to revive. After an initial slowdown in the current quarter, many analysts believe growth will achieve stronger gains for the rest of the year, allowing GDP to expand roughly 5% for 2021 as a whole.

Yet that forecast hinges on the widespread use of vaccines and the gradual reopening of businesses and the rehiring of millions of laid-off workers. The prospect of increased support from Congress’ approval of at least part of President Joe Biden’s $1.9 trillion relief plan and pent-up spending from the savings buildup of higher-income households has also raised hopes. A $900 billion rescue aid package that the government enacted late last year is providing some help, too.

On Wednesday, the Federal Reserve kept its benchmark short-term interest rate near zero and stressed that it would keep pursuing its low-rate policies until a recovery is well underway. The Fed acknowledged that the economy has faltered in recent months, with hiring weakening especially in industries affected by the raging pandemic, notably restaurants, bars, hotels and others involved in face-to-face public contact.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More